We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GSK plc | NYSE:GSK | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.29 | 0.67% | 43.74 | 2,038 | 09:05:46 |
LONDON-- GlaxoSmithKline PLC (GSK.LN) Wednesday said it has submitted a request to the European Medicines Agency for a variation to the marketing authorization for its anemia treatment eltrombopag after conducting two studies on the treatment.
Shares at 1312 GMT, up 1 pence, or 0.7%, at 1,441 pence valuing the company at GBP70 billion.
-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter: @RoryGallivan
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions